ABBVIE INC CEDEAR EA 10 REP 1 COM(USD)
19.45USDD
+0.40+2.10%
As of today at 20:00 GMT
USD
No trades
Key facts today
A lead plaintiff deadline of June 3, 2025, has been set for AbbVie (ABBV) shareholders involved in a lawsuit over undisclosed facts about AbbVie's interest in acquiring Cerevel.
AbbVie is pushing for U.S. tax code changes to boost domestic production amid ongoing Congressional talks on tax reforms that may benefit the pharmaceutical industry.
3.76 B USD
50.04 B USD
About AbbVie Inc.
Sector
Industry
CEO
Robert A. Michael
Website
Headquarters
North Chicago
Founded
2011
ISIN
ARBCOM4603M9
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
−4%
0%
4%
8%
12%
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
−5.00 B
0.00
5.00 B
10.00 B
15.00 B
Revenue
Net income
Net margin %
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
0.00
3.50 B
7.00 B
10.50 B
14.00 B
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
0.00
3.50 B
7.00 B
10.50 B
14.00 B
No news here
Looks like there's nothing to report right now
New Setup: ABBVABBV : I have a swing trade setup signal. I'm looking to enter long if the stock can manage to CLOSE above the last candle high(BUY). If triggered, I will then place a stop-loss below (SL) and a price target above it(TP) **Note: This setups will remain valid until the stock CLOSES BELOW my stop-loss
$ABBV Breakout About AbbVie, Inc.
AbbVie, Inc. is a leading biopharmaceutical company developing and selling treatments for various serious health conditions. Here's a brief overview:
* Founded on October 19, 2011
* Headquartered in North Chicago, IL
* Focus areas include:
+ Chronic autoimmune diseases (rheumat
NLong

$ABBV with a bullish outlook following its earnings #StocksThe PEAD projected a bullish outlook for NYSE:ABBV after a positive under reaction following its earnings release placing the stock in drift A with an expected accuracy of 75%.
NLong

ABBV AbbVie Options Ahead of EarningsIf you haven`t bought ABBV before the previous earnings:
Now analyzing the options chain and the chart patterns of ABBV AbbVie prior to the earnings report this week,
I would consider purchasing the 175usd strike price Calls with
an expiration date of 2025-2-21,
for a premium of approximately $6.2
NLong

ABBV - Are you Ready?Hello TradingView Family / Fellow Traders. This is Richard, also known as theSignalyst.
📈ABBV has been in a correction phase and it is currently approaching the lower bound of the red and blue channels.
Moreover, the green zone is a strong round number $150 and structure!
🏹 Thus, the highlighte
Major Price Movement Incoming for ABBV!Signalist has detected a precise pattern in NYSE:ABBV FUBO trading activity, signaling that a substantial price movement is imminent. This isn’t a random fluctuation—it’s a carefully analyzed precursor to a significant market event.
📅 What to Expect:
⌛ Timeline: Anticipate a major move within th
Abbvie...ready to move up now
NYSE:ABBV is ready to move now.
After the stock started ignoring bad news, and made a higher low, it is showing constructive signs.
It has now closed above the Daily 50 SMA now and broken out of the weekly consilidation.
Currently a double inside-month contender.
Gap above at ~181 and ATHs abov
NLong

See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
4ABC
ABBVIE 15/25Yield to maturity
8.35%
Maturity date
May 14, 2025
ABBV5068387
AbbVie Inc. 4.25% 21-NOV-2049Yield to maturity
6.26%
Maturity date
Nov 21, 2049
US287YAW9
ABBVIE 16/46Yield to maturity
6.13%
Maturity date
May 14, 2046
ABBV4036937
AbbVie Inc. 4.4% 06-NOV-2042Yield to maturity
6.11%
Maturity date
Nov 6, 2042
ABBV4693583
AbbVie Inc. 4.875% 14-NOV-2048Yield to maturity
6.05%
Maturity date
Nov 14, 2048
ABBV5068390
AbbVie Inc. 4.75% 15-MAR-2045Yield to maturity
6.04%
Maturity date
Mar 15, 2045
ABBV5068388
AbbVie Inc. 4.625% 01-OCT-2042Yield to maturity
6.03%
Maturity date
Oct 1, 2042
See all ABBVD bonds
Curated watchlists where ABBVD is featured.